Appendix 4C

+Rule 4.7B

Quarterly report for entities subject to Listing Rule 4.7B

Introduced 31/03/00 Amended 30/09/01, 24/10/05, 17/12/10, 01/09/16

Name of entity ResApp Health Limited ABN Quarter ended ("current quarter") 31 December 2016 51 094 468 318

Consolidated statement of cash flows

Current quarter

$A'000

Year to date (6 months)

$A'000

  1. Cash flows from operating activities

    1. Receipts from customers

    2. Payments for

      1. research and development

      2. product manufacturing and operating costs

      3. advertising and marketing

      4. leased assets

      5. staff costs

      6. administration and corporate costs

      7. Dividends received (see note 3)

      8. Interest received

      9. Interest and other costs of finance paid

      10. Income taxes paid

      11. Government grants and tax incentives

      12. Other (provide details if material)

      13. 1.9 Net cash from / (used in) operating activities

      -

      -

      (514)

      (732)

      -

      -

      -

      (20)

      -

      -

      (274)

      (485)

      (368)

      (654)

      -

      -

      10

      63

      (1)

      (2)

      -

      -

      -

      -

      -

      -

      (1,147)

      (1,830)

      1. Cash flows from investing activities
        1. Payments to acquire:

          1. property, plant and equipment - -

          2. businesses (see item 10) - -

          3. investments - -

          4. Consolidated statement of cash flows

            Current quarter

            $A'000

            Year to date (6 months)

            $A'000

            (d) intellectual property

            -

            -

            (e) other non-current assets

            -

            -

            2.2

            Proceeds from disposal of:

            (a) property, plant and equipment

            -

            -

            (b) businesses (see item 10)

            -

            -

            (c) investments

            -

            -

            (d) intellectual property

            -

            -

            (e) other non-current assets

            -

            -

            2.3

            Cash flows from loans to other entities

            -

            -

            2.4

            Dividends received (see note 3)

            -

            -

            2.5

            Other (provide details if material)

            -

            -

            2.6

            Net cash from / (used in) investing

            -

            -

            activities

            1. Cash flows from financing activities

              1. Proceeds from issues of shares

              2. Proceeds from issue of convertible notes

              3. Proceeds from exercise of share options

              4. Transaction costs related to issues of shares, convertible notes or options

              5. Proceeds from borrowings

              6. Repayment of borrowings

              7. Transaction costs related to loans and borrowings

              8. Dividends paid

              9. Other (provide details if material)

              10. 3.10 Net cash from / (used in) financing activities

              -

              - 232

              -

              -

              -

              -

              -

              -

              -

              - 266

              -

              -

              -

              -

              -

              -

              232

              266

              4.

              Net increase / (decrease) in cash and cash equivalents for the period

              4.1

              Cash and cash equivalents at beginning of quarter/year to date

              13,086

              13,735

              4.2

              Net cash from / (used in) operating activities (item 1.9 above)

              (1,147)

              (1,830)

              4.3

              Net cash from / (used in) investing activities (item 2.6 above)

              -

              -

              4.4

              Net cash from / (used in) financing activities (item 3.10 above)

              232

              266

              Consolidated statement of cash flows

              Current quarter

              $A'000

              Year to date (6 months)

              $A'000

              4.5 Effect of movement in exchange rates on cash held

              4.6 Cash and cash equivalents at end of quarter

              -

              -

              12,171

              12,171

              5. Reconciliation of cash and cash equivalents

              at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts

              Current quarter

              $A'000

              Previous quarter

              $A'000

              5.1

              Bank balances

              12,171

              13,086

              5.2

              Call deposits

              -

              -

              5.3

              Bank overdrafts

              -

              -

              5.4

              Other (provide details)

              -

              -

              5.5

              Cash and cash equivalents at end of

              12,171

              13,086

              quarter (should equal item 4.6 above)

              Current quarter

              $A'000

              275

              1. Payments to directors of the entity and their associates
                1. Aggregate amount of payments to these parties included in item 1.2

                2. Aggregate amount of cash flow from loans to these parties included in item 2.3

                3. Include below any explanation necessary to understand the transactions included in items 6.1 and 6.2

                  1. Director fees, salary and super;

                  2. Consultancy fees; and

                  3. Reimbursements.

                  4. Current quarter

                    $A'000

                  5. Payments to related entities of the entity and their associates
                    1. Aggregate amount of payments to these parties included in item 1.2

                    2. Aggregate amount of cash flow from loans to these parties included in item 2.3

                    3. Include below any explanation necessary to understand the transactions included in items 7.1 and 7.2

                      Total facility amount at quarter end

                      $A'000

                      Amount drawn at quarter end

                      $A'000

                      -

                      -

                      -

                      -

                      -

                      -

                    4. Financing facilities available Add notes as necessary for an understanding of the position
                      1. Loan facilities

                      2. Credit standby arrangements

                      3. Other (please specify)

                      4. Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well.

                      5. 9. Estimated cash outflows for next quarter

                        $A'000

                        9.1

                        Research and development

                        (1,640)

                        9.2

                        Product manufacturing and operating costs

                        -

                        9.3

                        Advertising and marketing

                        -

                        9.4

                        Leased assets

                        -

                        9.5

                        Staff costs

                        (275)

                        9.6

                        Administration and corporate costs

                        (250)

                        9.7

                        Other (provide details if material)

                        -

                        9.8

                        Total estimated cash outflows

                        (2,165)

                        10. Acquisitions and disposals of business entities

                        (items 2.1(b) and 2.2(b) above)

                        Acquisitions

                        Disposals

                        10.1

                        Name of entity

                        -

                        -

                        10.2

                        Place of incorporation or registration

                        -

                        -

                        10.3

                        Consideration for acquisition or disposal

                        -

                        -

                        10.4

                        Total net assets

                        -

                        -

                        10.5

                        Nature of business

                        -

                        -

                    ResApp Health Limited published this content on 30 January 2017 and is solely responsible for the information contained herein.
                    Distributed by Public, unedited and unaltered, on 29 January 2017 22:50:05 UTC.

                    Original documenthttp://www.resapphealth.com.au/wp-content/uploads/2017/01/1638828.pdf

                    Public permalinkhttp://www.publicnow.com/view/67ECB7104E9960FE64EA6BCA0B90FE68E0DD7CCE